What is Eli Health?
Eli Health offers the Hormometer, a pioneering instant hormone monitoring system designed to provide users with evidence-based insights into their hormone levels. The system includes tests for cortisol, progesterone, and testosterone, delivering results in approximately 20 minutes. This rapid feedback loop empowers individuals to understand their hormonal health and make informed daily decisions. Eli Health's commitment to advancing hormone testing is further evidenced by its portfolio of over 12 filed patents, aimed at ensuring high accuracy and accessibility in its diagnostic solutions. The company targets individuals keen on proactively managing their health through real-time hormonal data.
How much funding has Eli Health raised?
Eli Health has raised a total of $6.3M across 3 funding rounds:
Angel/Seed
$1.5M
Angel/Seed
$3.7M
Private Equity
$1.1M
Angel/Seed (2021): $1.5M with participation from Techstars, Vectr Ventures Limited, Real Ventures, Panache Ventures, Ramen Ventures, and 2048 Ventures
Angel/Seed (2023): $3.7M led by Cake Ventures, Muse Capital, and Garage Capital
Private Equity (2025): $1.1M, investors not publicly disclosed
Key Investors in Eli Health
Cake Ventures
Cake Ventures is a pre-seed and seed venture capital firm that invests in companies addressing demographic changes, focusing on founders with global ambitions in areas like aging and women's spending power.
Muse Capital
Muse Capital is an early-stage venture capital firm focused on investing in overlooked consumer technology opportunities in the sectors of care, play, and living, aiming to support founders shaping the future.
Garage Capital
Garage Capital is a venture capital firm dedicated to helping Canadian and Y Combinator startups transition from early-stage development to growth, providing support to build category-defining businesses.
What's next for Eli Health?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for Eli Health. This capital is anticipated to fuel further innovation in hormone monitoring technology, potentially expanding the range of tests offered and enhancing the user experience. Strategic partnerships and market penetration efforts are likely to be key priorities, leveraging the new financing to solidify Eli Health's position as a leader in personalized health diagnostics. The company's focus on patent-protected technology suggests a strategy geared towards long-term market dominance and continuous advancement in the health-tech landscape.
See full Eli Health company page
